Stuart Iain Insider Trades

Insider Trading History

Track insider trading activity for Stuart Iain. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
VYNE Therapeutics
VYNE Therapeutics VYNE
CHIEF SCIENTIFIC OFFICER
Holding Value $2.74M 95,944 shares
Last Trade
Jul 23, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$711k 15,405 shares
$46.17
$28.56
VYNE Therapeutics
VYNE Therapeutics VYNE
CHIEF SCIENTIFIC OFFICER
Holding Value $3.18M 111,349 shares
Last Trade
Jun 30, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$1.54k 2,370 shares
$0.65
$28.56
VYNE Therapeutics
VYNE Therapeutics VYNE
CHIEF SCIENTIFIC OFFICER
Holding Value $3.21M 112,363 shares
Last Trade
Mar 31, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$1.73k 2,876 shares
$0.60
$28.56
VYNE Therapeutics
VYNE Therapeutics VYNE
CHIEF SCIENTIFIC OFFICER
Holding Value $3.29M 115,239 shares
Last Trade
Dec 31, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$1.42k 2,448 shares
$0.58
$28.56
VYNE Therapeutics
VYNE Therapeutics VYNE
CHIEF SCIENTIFIC OFFICER
Holding Value $3.36M 117,687 shares
Last Trade
Sep 30, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$834 2,453 shares
$0.34
$28.56
VYNE Therapeutics
VYNE Therapeutics VYNE
CHIEF SCIENTIFIC OFFICER
Holding Value $3.43M 120,140 shares
Last Trade
Jun 30, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$4.05k 2,453 shares
$1.65
$28.56
VYNE Therapeutics
VYNE Therapeutics VYNE
CHIEF SCIENTIFIC OFFICER
Holding Value $3.5M 122,593 shares
Last Trade
Mar 31, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$9.55k 6,044 shares
$1.58
$28.56
VYNE Therapeutics
VYNE Therapeutics VYNE
CHIEF SCIENTIFIC OFFICER
Holding Value $6.57M 230,000 shares
Last Trade
Jan 21, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$637k 230,000 shares
$2.77
$28.56
VYNE Therapeutics
VYNE Therapeutics VYNE
CHIEF SCIENTIFIC OFFICER
Holding Value $3.67M 128,637 shares
Last Trade
Dec 31, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$16.3k 4,857 shares
$3.35
$28.56
VYNE Therapeutics
VYNE Therapeutics VYNE
CHIEF SCIENTIFIC OFFICER
Holding Value $3.81M 133,494 shares
Last Trade
Sep 30, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$205 109 shares
$1.88
$28.56
VYNE Therapeutics
VYNE Therapeutics VYNE
CHIEF SCIENTIFIC OFFICER
Holding Value $3.82M 133,603 shares
Last Trade
Jul 01, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$265 138 shares
$1.92
$28.56
VYNE Therapeutics
VYNE Therapeutics VYNE
CHIEF SCIENTIFIC OFFICER
Holding Value $3.82M 133,741 shares
Last Trade
Apr 01, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$484 157 shares
$3.08
$28.56
VYNE Therapeutics
VYNE Therapeutics VYNE
Chief Scientific Officer
Holding Value $3.82M 133,898 shares
Last Trade
Jan 02, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$358 157 shares
$2.28
$28.56
VYNE Therapeutics
VYNE Therapeutics VYNE
Chief Scientific Officer
Holding Value $3.83M 134,055 shares
Last Trade
Jan 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$291k 125,000 shares
$2.33
$28.56
VYNE Therapeutics
VYNE Therapeutics VYNE
Chief Scientific Officer
Holding Value $2.04M 71,555 shares
Last Trade
Dec 13, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$338k 125,000 shares
$2.70
$28.56
VYNE Therapeutics
VYNE Therapeutics VYNE
Chief Scientific Officer
Holding Value $259k 9,055 shares
Last Trade
Oct 02, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$4.53k 1,184 shares
$3.83
$28.56
VYNE Therapeutics
VYNE Therapeutics VYNE
Chief Scientific Officer
Holding Value $292k 10,239 shares
Last Trade
Jun 30, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$619 151 shares
$4.10
$28.56
VYNE Therapeutics
VYNE Therapeutics VYNE
Chief Scientific Officer
Holding Value $297k 10,390 shares
Last Trade
Mar 31, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$1.48k 480 shares
$3.08
$28.56
VYNE Therapeutics
VYNE Therapeutics VYNE
Chief Scientific Officer
Holding Value $6.29M 220,252 shares
Last Trade
Dec 31, 2022 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$258 1,720 shares
$0.15
$28.56
VYNE Therapeutics
VYNE Therapeutics VYNE
Chief Scientific Officer
Holding Value $6.34M 221,972 shares
Last Trade
Sep 30, 2022 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$378 1,719 shares
$0.22
$28.56

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up